Crossmark

Novel parathyroid hormone-based bone graft substitute, KUR-111, in treatment of tibial plateau fractures: a prospective, randomised, open-label, multicenter study

Crossref DOI link: https://doi.org/10.1007/s00590-025-04645-2

Published Online: 2026-01-14

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kanakaris, Nikolaos K

Raschke, Michael J

Lane, Joe M

Ryaby, James T

Atkinson, Brent L

Giannoudis, Peter V
Funding

Funding for this research was provided by:

Kuros Biosurgery AG
License Information

Text and Data Mining valid from 2026-01-14

Version of Record valid from 2026-01-14
More Information

Article History

Received: 28 November 2025

Accepted: 7 December 2025

First Online: 14 January 2026

Declarations

:

: The authors’ institutions were awarded a research grant from the sponsor of this trial during its duration for overhead and consumable costs, following approval by their local Research Ethics Committees. One of the authors was an employee of the sponsor of this trial (Kuros Biosurgery AG).

Document is current

Any future updates will be listed below